Urobiotic-250

Urobiotic-250 Benefits, Uses, Side Effects, Dosage Info

Urobiotic-250 is a prescription medication used to treat genitourinary infections. It is a combination of three active ingredients: oxytetracycline HCl, sulfamethizole, and phenazopyridine HCl. Manufactured by Pfizer, Urobiotic-250 is available in the form of yellow/light green capsule-shaped capsules imprinted with “PFIZER 092”.

Chemical Composition

Each Urobiotic-250 capsule contains:

Pharmacological Classification

Urobiotic-250 is a combination of three different classes of drugs:

Indications and Uses

Urobiotic-250 is indicated for the treatment of genitourinary infections caused by susceptible organisms. The tetracycline and sulfonamide components provide antibacterial activity, while the phenazopyridine component helps relieve pain, burning, and discomfort associated with urinary tract infections (UTIs).

The medication works by inhibiting bacterial protein synthesis (tetracycline and sulfonamide) and providing local analgesia (phenazopyridine) to alleviate symptoms of UTIs.

Sources:

Dosage and Administration

The recommended dosage of Urobiotic-250 is one capsule every 12 hours or as directed by a healthcare provider. The capsules should be swallowed whole with a full glass of water.

Dosage adjustments may be required for patients with renal impairment or other medical conditions. It is essential to follow the prescribed dosage and duration of therapy.

Sources:

Side Effects and Adverse Reactions

Common side effects of Urobiotic-250 may include:

Severe adverse reactions, although rare, may include allergic reactions, liver toxicity, and blood dyscrasias.

If any severe or persistent side effects occur, it is crucial to seek medical attention immediately.

Sources:

Drug Interactions

Urobiotic-250 may interact with various medications, including:

It is essential to inform your healthcare provider about all medications, supplements, and vitamins you are taking to avoid potential interactions.

Sources:

Contraindications and Precautions

Urobiotic-250 is contraindicated in patients with:

Precautions should be taken in patients with:

Sources:

Patient Information

Urobiotic-250 should be taken as prescribed by a healthcare provider. Patients should:

It is crucial to inform the healthcare provider about any other medications, supplements, or medical conditions before starting Urobiotic-250 therapy.

Sources:

Clinical Efficacy

Clinical trials have demonstrated the efficacy of Urobiotic-250 in treating genitourinary infections caused by susceptible organisms. The combination of antibiotics and analgesic components provides effective symptom relief and bacterial eradication.

Comparative studies have shown that Urobiotic-250 has similar efficacy to other commonly used antibiotics for UTIs, with the added benefit of providing pain relief.

Sources:

Alternatives and Comparisons

Alternative medications for the treatment of genitourinary infections include:

The choice of alternative therapy may depend on factors such as the causative organism, patient’s medical history, and cost considerations.

Head-to-head comparisons and cost-effectiveness analyses can help healthcare providers choose the most appropriate treatment option.

Sources:

Material Safety Data

Urobiotic-250 belongs to the tetracycline, sulfonamide, and local analgesic chemical families. Safety precautions should be taken when handling the capsules, including:

In case of accidental exposure, seek medical attention immediately.

Sources:

Historical and Vintage Information

Urobiotic-250 has been on the market for several decades, initially introduced as a combination therapy for genitourinary infections. Vintage packaging and bottles of the medication can be of interest to collectors and historians.

Historical usage trends and patterns can provide insights into the evolution of treatment approaches for UTIs and related conditions.

Sources:

Patient Experiences and Reviews

Patient reviews and testimonials can provide valuable insights into the real-world experiences with Urobiotic-250. Common themes in user ratings and reviews include:

It is important to note that individual experiences may vary, and healthcare provider guidance should be sought for personalized treatment decisions.

Sources:

Regulatory and Legal Information

Urobiotic-250 is an FDA-approved prescription medication. Its approval history and regulatory status are subject to ongoing monitoring and updates.

Patent information and potential legal issues or recalls related to the medication should be considered by healthcare providers and patients.

Sources:

Research and Development

Ongoing clinical studies and research are investigating the potential for new applications or formulations of Urobiotic-250 or its individual components.

Recent research findings may shed light on the mechanisms of action, pharmacokinetics, or potential synergistic effects of the combination therapy.

Future directions in treatment may involve exploring alternative delivery methods or combination therapies to enhance efficacy and minimize side effects.

Sources:

Expert Opinion

Healthcare providers, pharmacists, and medical experts can offer valuable insights and recommendations regarding the use of Urobiotic-250. Expert opinions may cover topics such as:

Expert interviews, articles, and professional resources can provide up-to-date and authoritative information on the safe and effective use of Urobiotic-250.

Sources:

FAQs

Some frequently asked questions by patients regarding Urobiotic-250 include: